Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma
Status:
Recruiting
Trial end date:
2024-08-20
Target enrollment:
Participant gender:
Summary
This study will research untreated non-germinal center diffuse large B cell lymphoma and what
causes the disease and the way patients respond to pembrolizumab combined with R-CHOP
chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone)
therapy.